ArticleScientific reports2019

Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death.

Ligia I Bastea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.